Trials / Completed
CompletedNCT01665599
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
A Phase 3, Open-label, Non-randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone concentrations \<300 ng/dL. The purpose of this study is to evaluate the safety and efficacy of testosterone gel (2%) delivered using an applicator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone gel (FE 999303) |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-04-01
- Completion
- 2013-05-01
- First posted
- 2012-08-15
- Last updated
- 2017-10-26
- Results posted
- 2017-09-20
Locations
19 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01665599. Inclusion in this directory is not an endorsement.